Cristaliza??o do princ?pio ativo farmac?utico glibenclamida por processo de precipita??o com antissolvente l?quido

Detalhes bibliográficos
Autor(a) principal: Costa, Camila Stefanne Dias
Data de Publicação: 2015
Tipo de documento: Dissertação
Idioma: por
Título da fonte: Biblioteca Digital de Teses e Dissertações da UFRRJ
Texto Completo: https://tede.ufrrj.br/jspui/handle/jspui/2779
Resumo: Diabetes mellitus (DM) is a chronic disease characterized by persistent hyperglycemia resulting from insulin resistance and/or deficiency. It is a metabolic disorder with high healthcare impact worldwide because of its chronic complications and high mortality rate. Type II diabetic patients can control their glycemic levels with the use of hypoglycemic drugs. Glibenclamide is a potent oral hypoglycemic drug that has been used in the treatment of DM-II, however, it has low water solubility and slow dissolution rate. In this study, glibenclamide microparticles were produced by the antisolvent precipitation process using water as the antisolvent. The four-factor three-level orthogonal array design OA9(3)4 proposed by Genichi Taguchi was used to investigate the effect of the following four factors on particle size and morphology: glibenclamide solution concentration [mg.mL-1], antisolvent/solvent volume ratio [A/S], stirring intensity [rpm], and surfactant concentration [% wt/wt]. Crystallized glibenclamide particles were characterized by optical microscopy, X-ray diffraction, and Fourier Transform Infrared Spectroscopy; the dissolution rate was characterized by HPLC. The surfactant concentration had a significant effect on the mean particle diameters of crystallized glibenclamide, followed by drug solution concentration, antisolvent/solvent volume ratio and stirring intensity, and the smaller sizes were observed with 1,0 mg.mL-1, A/S 10, 1500 rpm and 0,002 % wt/wt. The results indicate that crystallinity and chemical structure were not changed, however, the morphology and dissolution rate were affected by the factors. The results in this study show that the antisolvent precipitation process is effective in the preparation of microparticles of poorly water-soluble drugs. These contributions could expand the potential for new therapeutic drugs with low dissolution rates.
id UFRRJ-1_95fa8ee2d6656305e92e6596285956be
oai_identifier_str oai:localhost:jspui/2779
network_acronym_str UFRRJ-1
network_name_str Biblioteca Digital de Teses e Dissertações da UFRRJ
repository_id_str
spelling Coelho, Gerson Luiz Vieira376.071.627-04Coelho, Gerson Luiz VieiraMedronho, Ricardo de AndradeCal?ada, Lu?s Am?rico103.056.986-05http://lattes.cnpq.br/5668922585391362Costa, Camila Stefanne Dias2019-07-03T20:53:21Z2015-02-23COSTA, Camila Stefanne Dias. Cristaliza??o do princ?pio ativo farmac?utico glibenclamida por processo de precipita??o com antissolvente l?quido. 2015. 70 f. Disserta??o (Mestrado em Engenharia Qu?mica). Instituto de Tecnologia, Departamento de Engenharia Qu?mica, Universidade Federal Rural do Rio de Janeiro, Serop?dica, 2015.https://tede.ufrrj.br/jspui/handle/jspui/2779Diabetes mellitus (DM) is a chronic disease characterized by persistent hyperglycemia resulting from insulin resistance and/or deficiency. It is a metabolic disorder with high healthcare impact worldwide because of its chronic complications and high mortality rate. Type II diabetic patients can control their glycemic levels with the use of hypoglycemic drugs. Glibenclamide is a potent oral hypoglycemic drug that has been used in the treatment of DM-II, however, it has low water solubility and slow dissolution rate. In this study, glibenclamide microparticles were produced by the antisolvent precipitation process using water as the antisolvent. The four-factor three-level orthogonal array design OA9(3)4 proposed by Genichi Taguchi was used to investigate the effect of the following four factors on particle size and morphology: glibenclamide solution concentration [mg.mL-1], antisolvent/solvent volume ratio [A/S], stirring intensity [rpm], and surfactant concentration [% wt/wt]. Crystallized glibenclamide particles were characterized by optical microscopy, X-ray diffraction, and Fourier Transform Infrared Spectroscopy; the dissolution rate was characterized by HPLC. The surfactant concentration had a significant effect on the mean particle diameters of crystallized glibenclamide, followed by drug solution concentration, antisolvent/solvent volume ratio and stirring intensity, and the smaller sizes were observed with 1,0 mg.mL-1, A/S 10, 1500 rpm and 0,002 % wt/wt. The results indicate that crystallinity and chemical structure were not changed, however, the morphology and dissolution rate were affected by the factors. The results in this study show that the antisolvent precipitation process is effective in the preparation of microparticles of poorly water-soluble drugs. These contributions could expand the potential for new therapeutic drugs with low dissolution rates.Diabetes mellitus (DM) ? uma doen?a cr?nica caracterizada pela constante hiperglicemia sangu?nea resultante da resist?ncia e/ou defici?ncia na a??o da insulina. ? uma desordem metab?lica de grande impacto na sa?de mundial devido ? suas complica??es cr?nicas e alta taxa de mortalidade. Pacientes diagnosticados com o diabetes do tipo II podem controlar o n?vel glic?mico com o uso de hipoglicemiantes. A Glibenclamida ? um potente hipoglicemiante oral que tem sido utilizado no tratamento do DM-II, entretanto, possui baixa solubilidade aquosa e lenta taxa de dissolu??o. Neste estudo, micropart?culas de glibenclamida foram produzidas por processo de precipita??o com antissolvente l?quido usando ?gua como antissolvente. O design ortogonal OA9(3)4 proposto por Genichi Taguchi foi utilizado para investigar o efeito dos seguintes quatro fatores no tamanho e morfologia das part?culas: concentra??o da solu??o [mg.mL-1], raz?o de volume antissolvente/solvente [A/S], intensidade de agita??o [rpm] e concentra??o de aditivo [% m/m]. As part?culas de glibenclamida cristalizadas foram caracterizadas por microscopia ?tica, difra??o de raios-X e espectroscopia no infravermelho com Transformada de Fourier; a taxa de dissolu??o foi caracterizada por cromatografia l?quida de alta efici?ncia. A concentra??o de aditivo teve um significante efeito no di?metro m?dio das part?culas cristalizadas, seguida pela concentra??o da solu??o, raz?o de volume antissolvente/solvente e intensidade de agita??o, sendo que os menores di?metros foram obtidos quando os seguintes n?veis foram utilizados: 1,0 mg.mL-1, A/S 10, 1500 rpm e 0,002 % m/m. Os resultados neste estudo mostram que o processo de precipita??o com antissolvente ? efetivo na prepara??o de micropart?culas de drogas insuficientemente sol?veis em ?gua. Estas contribui??es poderiam expandir o potencial terap?utico de outras drogas de baixa solubilidade aquosa.Submitted by Jorge Silva (jorgelmsilva@ufrrj.br) on 2019-07-03T20:53:21Z No. of bitstreams: 1 2015 - Camila Stefanne Dias Costa.pdf: 2354534 bytes, checksum: 642d93d0ed7331950a12bc2e0e037a79 (MD5)Made available in DSpace on 2019-07-03T20:53:21Z (GMT). No. of bitstreams: 1 2015 - Camila Stefanne Dias Costa.pdf: 2354534 bytes, checksum: 642d93d0ed7331950a12bc2e0e037a79 (MD5) Previous issue date: 2015-02-23CAPESFAPERJapplication/pdfhttps://tede.ufrrj.br/retrieve/10141/2015%20-%20Camila%20Stefanne%20Dias%20Costa.pdf.jpghttps://tede.ufrrj.br/retrieve/16270/2015%20-%20Camila%20Stefanne%20Dias%20Costa.pdf.jpghttps://tede.ufrrj.br/retrieve/22564/2015%20-%20Camila%20Stefanne%20Dias%20Costa.pdf.jpghttps://tede.ufrrj.br/retrieve/28944/2015%20-%20Camila%20Stefanne%20Dias%20Costa.pdf.jpghttps://tede.ufrrj.br/retrieve/35296/2015%20-%20Camila%20Stefanne%20Dias%20Costa.pdf.jpghttps://tede.ufrrj.br/retrieve/41692/2015%20-%20Camila%20Stefanne%20Dias%20Costa.pdf.jpghttps://tede.ufrrj.br/retrieve/48094/2015%20-%20Camila%20Stefanne%20Dias%20Costa.pdf.jpghttps://tede.ufrrj.br/retrieve/54546/2015%20-%20Camila%20Stefanne%20Dias%20Costa.pdf.jpgporUniversidade Federal Rural do Rio de JaneiroPrograma de P?s-Gradua??o em Engenharia Qu?micaUFRRJBrasilInstituto de Tecnologiaglibenclamidaprecipita??o com antissolventecaracteriza??otaxa de dissolu??oglibenclamideantisolvent precipitationcharacterizationdissolution rateEngenharia Qu?micaCristaliza??o do princ?pio ativo farmac?utico glibenclamida por processo de precipita??o com antissolvente l?quidoCrystallization of the pharmaceutically active agent glibenclamide by the aqueous antisolvent precipitation processinfo:eu-repo/semantics/publishedVersioninfo:eu-repo/semantics/masterThesisinfo:eu-repo/semantics/openAccessreponame:Biblioteca Digital de Teses e Dissertações da UFRRJinstname:Universidade Federal Rural do Rio de Janeiro (UFRRJ)instacron:UFRRJTHUMBNAIL2015 - Camila Stefanne Dias Costa.pdf.jpg2015 - Camila Stefanne Dias Costa.pdf.jpgimage/jpeg3835http://localhost:8080/tede/bitstream/jspui/2779/18/2015+-+Camila+Stefanne+Dias+Costa.pdf.jpg34aa99b429e3554565886af0a861930bMD518TEXT2015 - Camila Stefanne Dias Costa.pdf.txt2015 - Camila Stefanne Dias Costa.pdf.txttext/plain148032http://localhost:8080/tede/bitstream/jspui/2779/17/2015+-+Camila+Stefanne+Dias+Costa.pdf.txt7941bc72d9c10f49ef7cdae41e728b06MD517ORIGINAL2015 - Camila Stefanne Dias Costa.pdf2015 - Camila Stefanne Dias Costa.pdfapplication/pdf2354534http://localhost:8080/tede/bitstream/jspui/2779/2/2015+-+Camila+Stefanne+Dias+Costa.pdf642d93d0ed7331950a12bc2e0e037a79MD52LICENSElicense.txtlicense.txttext/plain; charset=utf-82089http://localhost:8080/tede/bitstream/jspui/2779/1/license.txt7b5ba3d2445355f386edab96125d42b7MD51jspui/27792023-02-15 15:41:03.77oai:localhost: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Biblioteca Digital de Teses e Dissertaçõeshttps://tede.ufrrj.br/PUBhttps://tede.ufrrj.br/oai/requestbibliot@ufrrj.br||bibliot@ufrrj.bropendoar:2023-02-15T17:41:03Biblioteca Digital de Teses e Dissertações da UFRRJ - Universidade Federal Rural do Rio de Janeiro (UFRRJ)false
dc.title.por.fl_str_mv Cristaliza??o do princ?pio ativo farmac?utico glibenclamida por processo de precipita??o com antissolvente l?quido
dc.title.alternative.eng.fl_str_mv Crystallization of the pharmaceutically active agent glibenclamide by the aqueous antisolvent precipitation process
title Cristaliza??o do princ?pio ativo farmac?utico glibenclamida por processo de precipita??o com antissolvente l?quido
spellingShingle Cristaliza??o do princ?pio ativo farmac?utico glibenclamida por processo de precipita??o com antissolvente l?quido
Costa, Camila Stefanne Dias
glibenclamida
precipita??o com antissolvente
caracteriza??o
taxa de dissolu??o
glibenclamide
antisolvent precipitation
characterization
dissolution rate
Engenharia Qu?mica
title_short Cristaliza??o do princ?pio ativo farmac?utico glibenclamida por processo de precipita??o com antissolvente l?quido
title_full Cristaliza??o do princ?pio ativo farmac?utico glibenclamida por processo de precipita??o com antissolvente l?quido
title_fullStr Cristaliza??o do princ?pio ativo farmac?utico glibenclamida por processo de precipita??o com antissolvente l?quido
title_full_unstemmed Cristaliza??o do princ?pio ativo farmac?utico glibenclamida por processo de precipita??o com antissolvente l?quido
title_sort Cristaliza??o do princ?pio ativo farmac?utico glibenclamida por processo de precipita??o com antissolvente l?quido
author Costa, Camila Stefanne Dias
author_facet Costa, Camila Stefanne Dias
author_role author
dc.contributor.advisor1.fl_str_mv Coelho, Gerson Luiz Vieira
dc.contributor.advisor1ID.fl_str_mv 376.071.627-04
dc.contributor.referee1.fl_str_mv Coelho, Gerson Luiz Vieira
dc.contributor.referee2.fl_str_mv Medronho, Ricardo de Andrade
dc.contributor.referee3.fl_str_mv Cal?ada, Lu?s Am?rico
dc.contributor.authorID.fl_str_mv 103.056.986-05
dc.contributor.authorLattes.fl_str_mv http://lattes.cnpq.br/5668922585391362
dc.contributor.author.fl_str_mv Costa, Camila Stefanne Dias
contributor_str_mv Coelho, Gerson Luiz Vieira
Coelho, Gerson Luiz Vieira
Medronho, Ricardo de Andrade
Cal?ada, Lu?s Am?rico
dc.subject.por.fl_str_mv glibenclamida
precipita??o com antissolvente
caracteriza??o
topic glibenclamida
precipita??o com antissolvente
caracteriza??o
taxa de dissolu??o
glibenclamide
antisolvent precipitation
characterization
dissolution rate
Engenharia Qu?mica
dc.subject.eng.fl_str_mv taxa de dissolu??o
glibenclamide
antisolvent precipitation
characterization
dissolution rate
dc.subject.cnpq.fl_str_mv Engenharia Qu?mica
description Diabetes mellitus (DM) is a chronic disease characterized by persistent hyperglycemia resulting from insulin resistance and/or deficiency. It is a metabolic disorder with high healthcare impact worldwide because of its chronic complications and high mortality rate. Type II diabetic patients can control their glycemic levels with the use of hypoglycemic drugs. Glibenclamide is a potent oral hypoglycemic drug that has been used in the treatment of DM-II, however, it has low water solubility and slow dissolution rate. In this study, glibenclamide microparticles were produced by the antisolvent precipitation process using water as the antisolvent. The four-factor three-level orthogonal array design OA9(3)4 proposed by Genichi Taguchi was used to investigate the effect of the following four factors on particle size and morphology: glibenclamide solution concentration [mg.mL-1], antisolvent/solvent volume ratio [A/S], stirring intensity [rpm], and surfactant concentration [% wt/wt]. Crystallized glibenclamide particles were characterized by optical microscopy, X-ray diffraction, and Fourier Transform Infrared Spectroscopy; the dissolution rate was characterized by HPLC. The surfactant concentration had a significant effect on the mean particle diameters of crystallized glibenclamide, followed by drug solution concentration, antisolvent/solvent volume ratio and stirring intensity, and the smaller sizes were observed with 1,0 mg.mL-1, A/S 10, 1500 rpm and 0,002 % wt/wt. The results indicate that crystallinity and chemical structure were not changed, however, the morphology and dissolution rate were affected by the factors. The results in this study show that the antisolvent precipitation process is effective in the preparation of microparticles of poorly water-soluble drugs. These contributions could expand the potential for new therapeutic drugs with low dissolution rates.
publishDate 2015
dc.date.issued.fl_str_mv 2015-02-23
dc.date.accessioned.fl_str_mv 2019-07-03T20:53:21Z
dc.type.status.fl_str_mv info:eu-repo/semantics/publishedVersion
dc.type.driver.fl_str_mv info:eu-repo/semantics/masterThesis
format masterThesis
status_str publishedVersion
dc.identifier.citation.fl_str_mv COSTA, Camila Stefanne Dias. Cristaliza??o do princ?pio ativo farmac?utico glibenclamida por processo de precipita??o com antissolvente l?quido. 2015. 70 f. Disserta??o (Mestrado em Engenharia Qu?mica). Instituto de Tecnologia, Departamento de Engenharia Qu?mica, Universidade Federal Rural do Rio de Janeiro, Serop?dica, 2015.
dc.identifier.uri.fl_str_mv https://tede.ufrrj.br/jspui/handle/jspui/2779
identifier_str_mv COSTA, Camila Stefanne Dias. Cristaliza??o do princ?pio ativo farmac?utico glibenclamida por processo de precipita??o com antissolvente l?quido. 2015. 70 f. Disserta??o (Mestrado em Engenharia Qu?mica). Instituto de Tecnologia, Departamento de Engenharia Qu?mica, Universidade Federal Rural do Rio de Janeiro, Serop?dica, 2015.
url https://tede.ufrrj.br/jspui/handle/jspui/2779
dc.language.iso.fl_str_mv por
language por
dc.rights.driver.fl_str_mv info:eu-repo/semantics/openAccess
eu_rights_str_mv openAccess
dc.format.none.fl_str_mv application/pdf
dc.publisher.none.fl_str_mv Universidade Federal Rural do Rio de Janeiro
dc.publisher.program.fl_str_mv Programa de P?s-Gradua??o em Engenharia Qu?mica
dc.publisher.initials.fl_str_mv UFRRJ
dc.publisher.country.fl_str_mv Brasil
dc.publisher.department.fl_str_mv Instituto de Tecnologia
publisher.none.fl_str_mv Universidade Federal Rural do Rio de Janeiro
dc.source.none.fl_str_mv reponame:Biblioteca Digital de Teses e Dissertações da UFRRJ
instname:Universidade Federal Rural do Rio de Janeiro (UFRRJ)
instacron:UFRRJ
instname_str Universidade Federal Rural do Rio de Janeiro (UFRRJ)
instacron_str UFRRJ
institution UFRRJ
reponame_str Biblioteca Digital de Teses e Dissertações da UFRRJ
collection Biblioteca Digital de Teses e Dissertações da UFRRJ
bitstream.url.fl_str_mv http://localhost:8080/tede/bitstream/jspui/2779/18/2015+-+Camila+Stefanne+Dias+Costa.pdf.jpg
http://localhost:8080/tede/bitstream/jspui/2779/17/2015+-+Camila+Stefanne+Dias+Costa.pdf.txt
http://localhost:8080/tede/bitstream/jspui/2779/2/2015+-+Camila+Stefanne+Dias+Costa.pdf
http://localhost:8080/tede/bitstream/jspui/2779/1/license.txt
bitstream.checksum.fl_str_mv 34aa99b429e3554565886af0a861930b
7941bc72d9c10f49ef7cdae41e728b06
642d93d0ed7331950a12bc2e0e037a79
7b5ba3d2445355f386edab96125d42b7
bitstream.checksumAlgorithm.fl_str_mv MD5
MD5
MD5
MD5
repository.name.fl_str_mv Biblioteca Digital de Teses e Dissertações da UFRRJ - Universidade Federal Rural do Rio de Janeiro (UFRRJ)
repository.mail.fl_str_mv bibliot@ufrrj.br||bibliot@ufrrj.br
_version_ 1800313489416257536